Skip to main content
Premium Trial:

Request an Annual Quote

New Venter Center Study Aims to Map 10K Human Genomes in 10 Years

SAN DIEGO (GenomeWeb News) — The J. Craig Venter Institute plans to launch a large-scale human genome sequencing study that aims to map approximately 10,000 genomes within the next decade, a JCVI scientist said this week.

Next year, JCVI scientists plan to sequence between 10 and 50 individuals and evaluate a number of next-generation sequencing technologies, which could include tools made by Applied Biosystems, 454 Life Sciences, Illumina, and George Church, Sam Levy, a senior JCVI scientist, told GenomeWeb Daily News during the Genomes, Medicine, and the Environment Conference in San Diego this week.

Following the publication of Venter’s genome in PLoS Biology last month, 200 volunteers had offered to have their genomes sequenced, Levy said.

The institute is currently establishing an informed-consent protocol and deciding who will make up the first group of individuals to be sequenced.

The aim is to make this initial batch “as diverse as possible,” Levy said, including men and women, different ethnicities, as well as people with common diseases.

JCVI will design the study with Scripps Genomic Medicine and will obtain clinical samples with help from the Ludwig Institute for Cancer Research.

JCVI is also exploring ways to pay for the study, including encouraging volunteers to subsidize two other genomes, to be chosen by JCVI, in addition to their own, according to an institute spokeswoman.

Levy said that the estimated cost for sequencing a human genome on Applied Biosystems’ new SOLiD platform, which the institute expects to receive shortly, is about $300,000 “at a coverage level they say is sufficient.” Half the cost comprises reagents while the other half includes labor, overhead, and analysis costs.

JCVI is currently working with ABI to generate an additional 12X of coverage of Venter’s genome on the SOLiD system. It is also planning to fill gaps in the genome by targeted sequencing of fosmids and BAC clones, using a combination of 454’s and Illumina’s sequencing platforms, and to corroborate insertions and deletions using Nimblegen tiling arrays, according to Levy.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.